Stockscreener 앱 받기
6.66
3.20%
-0.22
시간 외 거래:
6.75
0.09
+1.35%
Karyopharm Therapeutics Inc 주식(KPTI)의 최신 뉴스
Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last? - Nasdaq
Smart tools for monitoring Karyopharm Therapeutics Inc.’s price actionWeekly Stock Recap & Weekly High Momentum Picks - newser.com
Karyopharm increases authorized shares, approves reverse split - MSN
Ideas Watch: Can Karyopharm Therapeutics Inc disrupt its industryMarket Sentiment Review & Weekly Top Gainers Alerts - خودرو بانک
Karyopharm Therapeutics Inc.(NasdaqGS: KPTI) dropped from S&P Global BMI Index - MarketScreener
Market Overview: Is Karyopharm Therapeutics Incs ROIC above industry average2025 Stock Rankings & Capital Efficiency Focused Ideas - خودرو بانک
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives $34.00 Consensus Price Target from Analysts - MarketBeat
Death Cross: Is Karyopharm Therapeutics Incs growth already priced inCEO Change & Fast Exit Strategy with Risk Control - khodrobank.com
Is Karyopharm Therapeutics Inc. stock entering bullish territoryJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - newser.com
Risk Check: Can Bread Financial Holdings Inc continue delivering strong returnsLayoff News & Free Accurate Trade Setup Notifications - خودرو بانک
Aug Rallies: Is Cartesian Growth Corporation Equity Warrant forming a double bottomEarnings Trend Report & Safe Entry Trade Signal Reports - khodrobank.com
Insider Buy: Will Karyopharm Therapeutics Inc. benefit from rate cuts2025 Key Highlights & Entry Point Confirmation Signals - خودرو بانک
Karyopharm CEO Paulson sells $8k in shares By Investing.com - Investing.com South Africa
Karyopharm therapeutics EVP Cheng sells $2089 in stock By Investing.com - Investing.com Canada
Karyopharm Therapeutics Board Member Resigns Amid Career Shift - MSN
Karyopharm therapeutics EVP Cheng sells $2089 in stock - Investing.com India
Karyopharm CEO Paulson sells $8k in shares - Investing.com India
Aug Wrap: Is SLM Corporation part of any major indexWeekly Market Report & Low Risk Profit Maximizing Plans - خودرو بانک
Gap Down: Is Karyopharm Therapeutics Inc gaining market share2025 Investor Takeaways & Technical Pattern Based Signals - خودرو بانک
Volatility Watch: What are Karyopharm Therapeutics Inc.’s recent SEC filings showingQuarterly Profit Report & AI Based Trade Execution Alerts - خودرو بانک
Entry Recap: Will Karyopharm Therapeutics Inc. benefit from current market trends2025 Top Gainers & Stock Portfolio Risk Control - خودرو بانک
Wall Street Recap: Is Karyopharm Therapeutics Inc gaining market shareJuly 2025 Action & Fast Gain Stock Tips - خودرو بانک
Volume Report: What are Karyopharm Therapeutics Inc.’s recent SEC filings showingWeekly Trade Report & Reliable Trade Execution Plans - khodrobank.com
These biotechs are in the market for a buyer - The Business Journals
Income Plays: Will Karyopharm Therapeutics Inc outperform its industry peersTrade Analysis Summary & Short-Term Swing Trade Alerts - خودرو بانک
Karyopharm Therapeutics Inc. $KPTI Position Reduced by Adage Capital Partners GP L.L.C. - MarketBeat
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Held Back By Insufficient Growth Even After Shares Climb 65% - simplywall.st
Karyopharm concludes enrolment in Phase III myelofibrosis treatment trial - Yahoo Finance
Karyopharm completes enrollment in phase 3 myelofibrosis trial By Investing.com - Investing.com Australia
Karyopharm completes enrollment in phase 3 myelofibrosis trial - Investing.com India
Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis - Citizen Tribune
Karyopharm announces completion of enrollment in the phase 3 SENTRY trial in myelofibrosis - MarketScreener
Published on: 2025-09-08 20:44:00 - beatles.ru
Karyopharm Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsWatch List & Technical Analysis for Trade Confirmation - beatles.ru
Palo Alto Investors LP Cuts Stock Holdings in Karyopharm Therapeutics Inc. $KPTI - MarketBeat
Birchview Capital LP Trims Holdings in Karyopharm Therapeutics Inc. $KPTI - MarketBeat
Is Karyopharm Therapeutics Inc. gaining market share2025 Earnings Surprises & Technical Analysis for Trade Confirmation - classian.co.kr
Analyzing recovery setups for Karyopharm Therapeutics Inc. investorsJuly 2025 Rallies & Verified Momentum Stock Ideas - Newser
Multi factor analysis applied to Karyopharm Therapeutics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - Newser
Will Karyopharm Therapeutics Inc. benefit from current market trendsMarket Weekly Review & Daily Stock Trend Reports - خودرو بانک
Can Karyopharm Therapeutics Inc. recover in the next quarterJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser
Is Karyopharm Therapeutics Inc. benefiting from innovation trendsJuly 2025 Trends & Free Community Supported Trade Ideas - خودرو بانک
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Karyopharm Therapeutics Inc. stock daily chart insights2025 Retail Activity & Low Drawdown Trading Techniques - Newser
Is Karyopharm Therapeutics Inc. trending in predictive chart modelsMarket Risk Report & Fast Moving Stock Watchlists - Newser
What candlestick patterns are forming on Karyopharm Therapeutics Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Using data tools to time your Karyopharm Therapeutics Inc. exitJuly 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Layoff Tracker: AC Immune To Cut 30% of Workforce - BioSpace
2.43%
자본화:
|
볼륨(24시간):